Cyclerion Therapeutics Inc

General ticker "CYCN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $7.9M

Cyclerion Therapeutics Inc does not follow the US Stock Market performance with the rate: -15.5%.

Estimated limits based on current volatility of -24.5%: low 3.01$, high 3.34$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [2.48$, 7.52$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.97$, 8.17$]

Financial Metrics affecting the CYCN estimates:

  • Negative: Non-GAAP EPS, $ of -6.64 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -75.69 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term CYCN quotes

Long-term CYCN plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $3.32MM $0.30MM $0.00MM
Operating Expenses $58.52MM $18.84MM $12.95MM
Operating Income $-55.20MM $-18.54MM $-12.95MM
Non-Operating Income $3.55MM $0.29MM $0.36MM
Interest Expense $0.02MM $0.00MM $0.00MM
R&D Expense $37.64MM $31.49MM $1.51MM
Income(Loss) $-51.65MM $-18.25MM $-12.59MM
Taxes $0.02MM $0.00MM $0.00MM
Other Income(Loss) $0.00MM $-25.83MM $7.33MM
Profit(Loss) $-51.66MM $-44.08MM $-5.26MM
Stockholders Equity $48.25MM $10.45MM $11.29MM
Inventory $0.93MM $0.81MM $0.00MM
Assets $59.33MM $18.08MM $13.37MM
Operating Cash Flow $-36.52MM $-40.61MM $-21.25MM
Capital expenditure $0.01MM $0.00MM $0.00MM
Investing Cash Flow $1.46MM $0.00MM $10.40MM
Financing Cash Flow $30.79MM $0.03MM $5.02MM
Earnings Per Share* $-26.40 $-20.15 $-8.99

* EPS are Split Adjusted, recent splits may be reflected with a delay.